Thomas Ciulla, Chief Officer of Viridian Therapeutics, Inc.\DE VRDN, has filed 0 purchases and 2 sales on the open market. The latest trade was on 24/02/05.

TC

TC

Thomas Ciulla

Chief Medical Officer

Company

Viridian Therapeutics, Inc.\DE VRDN

First filing

23/01/06

Trades

6 trades

Buys / sales

0 / 2

12-month net buying

No record

Last trade

24/02/05

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
CB Clearside Biomedical	Open-market sale	23/01/20	23/01/20	13,700 sh	$1.47	$20,139	−4.5%
CB Clearside Biomedical	Open-market sale	23/01/10	23/01/11	2,170 sh	$1.62	$3,515.4	−0.7%